PT-141
Bremelanotide, a synthetic peptide that acts on melanocortin receptors, injected under the skin. Approved in the United States in 2019 as Vyleesi for low sexual desire in premenopausal women; not approved in Canada, where it is sold as a research chemical.
Performance0 public stacks
Substance
PT-141
- Route
- Injection Injected
- Measured in
- mg milligrams
- Comes as
- vial pen
Also
Public stacks with it 0
No public stack has it yet.